Literature DB >> 33871199

Unconventional uses of common conventional drugs: A review.

Anupam Das1, Abheek Sil2, Shouvik Ghosh1, Saumya Panda3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33871199     DOI： 10.25259/IJDVL_389_20

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN： 0378-6323            Impact factor:   2.545


× No keyword cloud information.
  58 in total

1.  Treatment of subcutaneous sarcoidosis with allopurinol.

Authors:  S Voelter-Mahlknecht; A Benez; S Metzger; G Fierlbeck
Journal:  Arch Dermatol       Date:  1999-12

2.  Foreign body granulomas caused by polymethylmethacrylate microspheres: successful treatment with allopurinol.

Authors:  Eva-Maria Reisberger; Michael Landthaler; Luitgard Wiest; Josef Schröder; Wilhelm Stolz
Journal:  Arch Dermatol       Date:  2003-01

3.  A controlled trial of ondansetron in the pruritus of cholestasis.

Authors:  J W O'Donohue; S P Pereira; A C Ashdown; C G Haigh; J R Wilkinson; R Williams
Journal:  Aliment Pharmacol Ther       Date:  2005-04-15       Impact factor: 8.171

4.  Ivermectin therapy for papulopustular rosacea and periorificial dermatitis in children: A series of 15 cases.

Authors:  Lucero Noguera-Morel; Paula Gerlero; Antonio Torrelo; Ángela Hernández-Martín
Journal:  J Am Acad Dermatol       Date:  2017-03       Impact factor: 11.527

Review 5.  Colchicine: an ancient drug with novel applications.

Authors:  B Dasgeb; D Kornreich; K McGuinn; L Okon; I Brownell; D L Sackett
Journal:  Br J Dermatol       Date:  2018-01-03       Impact factor: 9.302

6.  Ondansetron for pruritus due to cholestasis.

Authors:  M Raderer; C Müller; W Scheithauer
Journal:  N Engl J Med       Date:  1994-05-26       Impact factor: 91.245

Review 7.  Targeting the TGFβ signalling pathway in disease.

Authors:  Rosemary J Akhurst; Akiko Hata
Journal:  Nat Rev Drug Discov       Date:  2012-09-24       Impact factor: 84.694

8.  Inhibitory influences of xanthine oxidase inhibitor and angiotensin I-converting enzyme inhibitor on multinucleated giant cell formation from monocytes by downregulation of adhesion molecules and purinergic receptors.

Authors:  K Mizuno; H Okamoto; T Horio
Journal:  Br J Dermatol       Date:  2004-02       Impact factor: 9.302

9.  Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms.

Authors:  Alexander Nyström; Kerstin Thriene; Venugopal Mittapalli; Johannes S Kern; Dimitra Kiritsi; Jörn Dengjel; Leena Bruckner-Tuderman
Journal:  EMBO Mol Med       Date:  2015-09       Impact factor: 12.137

10.  Systemic treatment in severe cases of recurrent aphthous stomatitis: an open trial.

Authors:  Maria Angela Martins Mimura; Silvio Kenji Hirota; Norberto Nobuo Sugaya; José Antonio Sanches; Dante Antonio Migliari
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.